{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T05:46:52Z","timestamp":1770529612132,"version":"3.49.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T00:00:00Z","timestamp":1235433600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s12640-009-9023-3","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T17:05:23Z","timestamp":1248109523000},"page":"224-231","source":"Crossref","is-referenced-by-count":52,"title":["Fifteen-Year Experience in Treating Blepharospasm with Botox or Dysport: Same Toxin, Two Drugs"],"prefix":"10.1007","volume":"15","author":[{"given":"A. R.","family":"Bentivoglio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ialongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Soleti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lo Fermo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Albanese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,24]]},"reference":[{"key":"9023_CR1","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0161-6420(95)30757-9","volume":"102","author":"JR Ainsworth","year":"1995","unstructured":"Ainsworth JR, Kraft SP (1995) Long-term changes in duration of relief with botulinum toxin treatment of essential blepharospasm and hemifacial spasm. Ophthalmology 102:2036\u20132040","journal-title":"Ophthalmology"},{"key":"9023_CR2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000116805","volume":"32","author":"A Albanese","year":"1992","unstructured":"Albanese A, Colosimo C, Carretta D, Dickmann A, Bentivoglio AR, Tonali P (1992) Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm. Eur Neurol 32:112\u2013117","journal-title":"Eur Neurol"},{"key":"9023_CR3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1468-1331.2006.01537.x","volume":"13","author":"A Albanese","year":"2006","unstructured":"Albanese A, Barnes MP, Bhatia KP, Fernandez E, Filippini G, Gasser T, Krauss JK, Newton A, Rektor I, Savoiardo M, Valls-Sol\u00e8 J (2006) A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes. Report by an EFNS\/MDS-ES Task Force. Eur J Neurol 13:433\u2013444","journal-title":"Eur J Neurol"},{"key":"9023_CR4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1185\/030079905X36396","volume":"21","author":"K Binari","year":"2005","unstructured":"Binari K (2005) Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm. Curr Med Res Opin 21:433\u2013438","journal-title":"Curr Med Res Opin"},{"key":"9023_CR5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/01658109209058127","volume":"12","author":"GE Borodic","year":"1992","unstructured":"Borodic GE, Ferrante R (1992) Effects of repeated botulinum toxin injections on orbicularis oculi muscle. J Clin Neuroophthalmol 12:121\u2013127","journal-title":"J Clin Neuroophthalmol"},{"key":"9023_CR6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mds.870090106","volume":"9","author":"GE Borodic","year":"1994","unstructured":"Borodic GE, Ferrante R, Pearce LB, Smith K (1994) Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov Disord 9:31\u201339","journal-title":"Mov Disord"},{"key":"9023_CR7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mds.870020402","volume":"2","author":"MF Brin","year":"1987","unstructured":"Brin MF, Fahn S, Moskovitz C, Friedman A, Shale HM, Greene PE, Blitzer A, List T, Lange D, Lovelace RE, McMahon D (1987) Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Mov Disord 2:237\u2013254","journal-title":"Mov Disord"},{"key":"9023_CR8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1212\/WNL.35.1.73","volume":"35","author":"RE Burke","year":"1985","unstructured":"Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J (1985) Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 35:73\u201377","journal-title":"Neurology"},{"key":"9023_CR9","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0161-6420(86)33520-6","volume":"93","author":"CL Burns","year":"1986","unstructured":"Burns CL, Gammon JA, Gemmill MC (1986) Ptosis associated with botulinum toxin treatment of strabismus and blepharospasm. Ophthalmology 93:1621\u20131627","journal-title":"Ophthalmology"},{"key":"9023_CR10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/PL00007849","volume":"249","author":"R Cakmur","year":"2002","unstructured":"Cakmur R, Ozturk V, Uzunel F, Donmez B, Idiman F (2002) Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neurol 249:64\u201368","journal-title":"J Neurol"},{"key":"9023_CR11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1017\/S0317167100026159","volume":"14","author":"J Carruthers","year":"1987","unstructured":"Carruthers J, Stubbs HA (1987) Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid entropion. Can J Neurol Sci 14:42\u201345","journal-title":"Can J Neurol Sci"},{"key":"9023_CR12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00002826-198610000-00002","volume":"9","author":"DA Cohen","year":"1986","unstructured":"Cohen DA, Savino PJ, Stern MB, Hurtig HI (1986) Botulinum injection therapy for blepharospasm: a review and report of 75 patients. Clin Neuropharmacol 9:415\u2013429","journal-title":"Clin Neuropharmacol"},{"key":"9023_CR13","first-page":"CD004900","volume":"1","author":"J Costa","year":"2005","unstructured":"Costa J, Espirito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C (2005) Botulinum toxin type A therapy for blepharospasm. Cochrane Database Syst Rev 1:CD004900","journal-title":"Cochrane Database Syst Rev"},{"key":"9023_CR14","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/jnnp.73.5.604","volume":"73","author":"D Dressler","year":"2002","unstructured":"Dressler D (2002) Dysport produces intrinsically more swallowing problems than Botox: unexpected results from a conversion factor study in cervical dystonia. J Neurol Neurosurg Psychiatry 73:604","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 1","key":"9023_CR15","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1111\/j.1468-1331.2006.01439.x","volume":"13","author":"D Dressler","year":"2006","unstructured":"Dressler D, Hallet M (2006) Immunological aspects of Botox, Dysport and Myobloc\/Neurobloc. Eur J Neurol 13(Suppl 1):S11\u2013S15","journal-title":"Eur J Neurol"},{"key":"9023_CR16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0022-510X(71)90129-8","volume":"14","author":"LW Duchen","year":"1971","unstructured":"Duchen LW (1971) An electron microscopic study of the changes induced by botulinum toxin in the motor end-plates of slow and fast skeletal muscle fibres of the mouse. J Neurol Sci 14:47\u201360","journal-title":"J Neurol Sci"},{"key":"9023_CR17","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0161-6420(88)32977-5","volume":"95","author":"JJ Dutton","year":"1988","unstructured":"Dutton JJ, Buckley EG (1988) Long-term results and complications of botulinum A toxin in the treatment of blepharospasm. Ophthalmology 95:1529\u20131534","journal-title":"Ophthalmology"},{"key":"9023_CR18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.33588\/rn.3806.2003433","volume":"38","author":"A Echeverria Urabayen","year":"2004","unstructured":"Echeverria Urabayen A, Fanjul S, Meseguer E, Garcia Ruiz Espiga PJ (2004) Progression of botulinum toxin type A dosage in craniocervical dystonias. An eight year comparative study. Rev Neurol 38:511\u2013513","journal-title":"Rev Neurol"},{"key":"9023_CR19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00839203","volume":"239","author":"JS Elston","year":"1992","unstructured":"Elston JS (1992) The management of blepharospasm and hemifacial spasm. J Neurol 239:5\u20138","journal-title":"J Neurol"},{"key":"9023_CR20","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1136\/bmj.290.6485.1857","volume":"290","author":"JS Elston","year":"1985","unstructured":"Elston JS, Russell RWR (1985) Effect of treatment with botulinum toxin on neurogenic blepharospasm. Br Med J 290:1857\u20131859","journal-title":"Br Med J"},{"key":"9023_CR21","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0161-6420(87)33338-X","volume":"94","author":"PF Engstrom","year":"1987","unstructured":"Engstrom PF, Arnoult JB, Mazow ML, Prager TC, Wilkins RB, Byrd WA, Hofmann RJ (1987) Effectiveness of botulinum toxin therapy for essential blepharospasm. Ophthalmology 94:971\u2013975","journal-title":"Ophthalmology"},{"issue":"Suppl 1","key":"9023_CR22","first-page":"S271","volume":"35","author":"S Fahn","year":"1985","unstructured":"Fahn S, List T, Moskowitz C, Brin M, Bressman S, Burke R, Scott A (1985) Double-blind controlled study of botulinum toxin for blepharospasm. Neurology 35(Suppl 1):S271\u2013S272","journal-title":"Neurology"},{"key":"9023_CR23","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0161-6420(86)33641-8","volume":"93","author":"BR Frueh","year":"1986","unstructured":"Frueh BR, Musch DC (1986) Treatment of facial spasm with botulinum toxin: an interim report. Ophthalmology 93:917\u2013923","journal-title":"Ophthalmology"},{"key":"9023_CR24","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/archopht.1984.01040031184014","volume":"102","author":"BR Frueh","year":"1984","unstructured":"Frueh BR, Felt TH, Wojno TH, Musch DC (1984) Treatment of blepharospasm with botulinum toxin: a preliminary report. Arch Ophtalmol 102:1464\u20131468","journal-title":"Arch Ophtalmol"},{"key":"9023_CR25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.51.6.767","volume":"51","author":"F Grandas","year":"1988","unstructured":"Grandas F, Elston J, Quinn N (1988) Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry 51:767\u2013772","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9023_CR26","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/mds.10252","volume":"17","author":"GY Hsiung","year":"2002","unstructured":"Hsiung GY, Das SK, Ranawaya R, Lafontaine AL, Suchowersky O (2002) Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. Mov Disord 17:1288\u20131293","journal-title":"Mov Disord"},{"key":"9023_CR27","first-page":"371","volume":"16","author":"J Jankovic","year":"1984","unstructured":"Jankovic J, Orman J (1984) Blepharospasm: demographic and clinical survey of 250 patients. Ann Ophthalmol 16:371\u2013376","journal-title":"Ann Ophthalmol"},{"key":"9023_CR28","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1212\/WNL.37.4.616","volume":"37","author":"J Jankovic","year":"1987","unstructured":"Jankovic J, Orman J (1987) Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology 37:616\u2013623","journal-title":"Neurology"},{"key":"9023_CR29","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/jnnp.53.8.633","volume":"53","author":"J Jankovic","year":"1990","unstructured":"Jankovic J, Schwartz K, Donovan DT (1990) Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 53:633\u2013639","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9023_CR30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/mds.870120116","volume":"12","author":"KR Kessler","year":"1997","unstructured":"Kessler KR, Benecke R (1997) The EBD test\u2014a clinical test for the detection of antibodies to botulinum toxin type A. Mov Disord 12:95\u201399","journal-title":"Mov Disord"},{"key":"9023_CR31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1017\/S0317167100027748","volume":"15","author":"SP Kraft","year":"1988","unstructured":"Kraft SP, Lang AE (1988) Botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, and eyelid fasciculations. Can J Neurol Sci 15:276\u2013280","journal-title":"Can J Neurol Sci"},{"key":"9023_CR32","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.ophtha.2006.03.055","volume":"113","author":"RL Levy","year":"2006","unstructured":"Levy RL, Berman D, Parikh M, Miller NR (2006) Supramaximal doses of botulinum toxin for refractory blepharospasm. Ophthalmology 113:1665\u20131668","journal-title":"Ophthalmology"},{"key":"9023_CR33","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/bjo.75.12.737","volume":"75","author":"JA Mauriello","year":"1991","unstructured":"Mauriello JA, Aijian J (1991) Natural history of treatment of facial dyskinesias with botulinum toxin: a study of 50 consecutive patients over seven years. Br J Ophthalmol 75:737\u2013739","journal-title":"Br J Ophthalmol"},{"key":"9023_CR34","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/bjo.80.12.1073","volume":"80","author":"JA Mauriello Jr","year":"1996","unstructured":"Mauriello JA Jr, Dhillon S, Leone T, Pakeman B, Mostafavi R, Yepez MC (1996) Treatment selections of 239 patients with blepharospasm and Meige syndrome over 11\u00a0years. Br J Ophthalmol 80:1073\u20131076","journal-title":"Br J Ophthalmol"},{"key":"9023_CR35","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0041-0101(96)00070-0","volume":"34","author":"K Mclellan","year":"1996","unstructured":"Mclellan K, Das RE, Ekong TA, Sesardic D (1996) Therapeutic botulinum type A toxin: factors affecting potency. Toxicon 34:975\u2013985","journal-title":"Toxicon"},{"key":"9023_CR36","first-page":"437","volume":"21","author":"H Meige","year":"1910","unstructured":"Meige H (1910) Les convulsions de la face: une forme clinique de convulsions faciales, bilaterale et mediane. Rev Neurol (Paris) 21:437\u2013443","journal-title":"Rev Neurol (Paris)"},{"key":"9023_CR37","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/mds.20376","volume":"20","author":"NI Mejia","year":"2005","unstructured":"Mejia NI, Vuong KD, Jankovic J (2005) Long-term botulinum toxin efficacy, safety, and immunogenicity. Mov Disord 20:592\u2013597","journal-title":"Mov Disord"},{"key":"9023_CR38","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1185\/030079904125003962","volume":"20","author":"M Naumann","year":"2004","unstructured":"Naumann M, Jankovic J (2004) Safety of botulinum toxin type A: a systematic review and meta-analysis. Curr Med Res Opin 20:981\u2013990","journal-title":"Curr Med Res Opin"},{"key":"9023_CR39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00941758","volume":"235","author":"Z Nussgens","year":"1997","unstructured":"Nussgens Z, Roggenkamper P (1997) Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm. Graefes Arch Clin Exp Ophthalmol 235:197\u2013199","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"9023_CR40","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1442-9071.2006.01236.x","volume":"34","author":"AL Pang","year":"2006","unstructured":"Pang AL, O\u2019day J (2006) Use of high-dose botulinum A toxin in benign essential blepharospasm: is too high too much? Clin Experiment Ophthalmol 34:441\u2013444","journal-title":"Clin Experiment Ophthalmol"},{"key":"9023_CR41","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3346\/jkms.1993.8.5.334","volume":"8","author":"YC Park","year":"1993","unstructured":"Park YC, Lim JK, Lee DK, Yi SD (1993) Botulinum a toxin treatment of Hemifacial spasm and blepharospasm. J Korean Med Sci 8:334\u2013340","journal-title":"J Korean Med Sci"},{"key":"9023_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0161-6420(86)33785-0","volume":"93","author":"KI Perman","year":"1986","unstructured":"Perman KI, Baylis HI, Rosenbaum AL, Kirschen DG (1986) The use of botulinum toxin in the medical management of benign essential blepharospasm. Ophthalmology 93:1\u20133","journal-title":"Ophthalmology"},{"key":"9023_CR43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1755-3768.1990.tb01933.x","volume":"68","author":"P Ruusuvaara","year":"1990","unstructured":"Ruusuvaara P, Set\u00e4l\u00e4 K (1990) Longterm treatment of involuntary facial spasms using botulinum toxin. Acta Ophthalmol 68:331\u2013338","journal-title":"Acta Ophthalmol"},{"key":"9023_CR44","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/mds.870120627","volume":"12","author":"C Sampaio","year":"1997","unstructured":"Sampaio C, Ferreira JJ, Simoes F, Rosas MJ, Magalhaes M, Correia AP, Bastos-Lima A, Martins R, Castro-Caldas A (1997) DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A-Dysport and Botox-assuming a ratio of 4:1. Mov Disord 12:1013\u20131018","journal-title":"Mov Disord"},{"issue":"Suppl 8","key":"9023_CR45","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1002\/mds.20066","volume":"19","author":"C Sampaio","year":"2004","unstructured":"Sampaio C, Costa J, Ferreira JJ (2004) Clinical comparability of marketed formulations of botulinum toxin. Mov Disord 19(Suppl 8):S129\u2013S136","journal-title":"Mov Disord"},{"key":"9023_CR46","first-page":"734","volume":"79","author":"AB Scott","year":"1981","unstructured":"Scott AB (1981) Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc 79:734\u2013770","journal-title":"Trans Am Ophthalmol Soc"},{"key":"9023_CR47","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archopht.1985.01050030043017","volume":"103","author":"AB Scott","year":"1985","unstructured":"Scott AB, Kennedy RA, Stubbs HA (1985) Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol 103:347\u2013350","journal-title":"Arch Ophthalmol"},{"key":"9023_CR48","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0002-9394(14)77954-1","volume":"99","author":"N Shorr","year":"1985","unstructured":"Shorr N, Seiff SR, Kopelman J (1985) The use of botulinum toxin in blepharospasm. Am J Ophthalmol 99:542\u2013546","journal-title":"Am J Ophthalmol"},{"key":"9023_CR49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1590\/S0004-282X2005000200006","volume":"63","author":"L Silveira-Moriyama","year":"2005","unstructured":"Silveira-Moriyama L, Goncalves LR, Chien HF, Barbosa ER (2005) Botulinum toxin a in the treatment of blepharospasm: a 10-year experience. Arq Neuropsiquiatr 63:221\u2013224","journal-title":"Arq Neuropsiquiatr"},{"key":"9023_CR50","first-page":"133","volume":"26","author":"JD Taylor","year":"1991","unstructured":"Taylor JD, Kraft SP, Kazdan MS, Flanders M, Cadera W, Orton RB (1991) Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicentre study. Can J Ophthalmol 26:133\u2013138","journal-title":"Can J Ophthalmol"},{"key":"9023_CR51","first-page":"206","volume":"47","author":"A Thussu","year":"1999","unstructured":"Thussu A, Barman CR, Prabhakar S (1999) Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation. Neurol India 47:206\u2013209","journal-title":"Neurol India"},{"key":"9023_CR52","first-page":"61","volume":"14","author":"CP Tsai","year":"2005","unstructured":"Tsai CP, Chiu MC, Yen DJ, Guo YC, Yuan CL, Lee TC (2005) Quantitative assessment of efficacy of dysport (botulinum toxin type A) in the treatment of idiopathic blepharospasm and hemifacial spasm. Acta Neurol Taiwan 14:61\u201368","journal-title":"Acta Neurol Taiwan"},{"key":"9023_CR53","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/mus.880180708","volume":"18","author":"P Bergh Van den","year":"1995","unstructured":"Van den Bergh P, Francart J, Mourin S, Kollmann P, Laterre EC (1995) Five year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin. Muscle Nerve 18:720\u2013729","journal-title":"Muscle Nerve"},{"key":"9023_CR54","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/PL00004951","volume":"355","author":"K Wohlfarth","year":"1997","unstructured":"Wohlfarth K, Goschel H, Frevert J, Dengler R, Bigalke H (1997) Botulinum A toxins: units versus units. Naunyn Schmiedebergs Arch Pharmacol 355:335\u2013340","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"9023_CR55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00002341-198601050-00003","volume":"2","author":"T Wojno","year":"1986","unstructured":"Wojno T, Campbell P, Wright J (1986) Orbicularis muscle pathology after botulinum toxin injection. Ophthal Plast Reconstr Surg 2:71\u201374","journal-title":"Ophthal Plast Reconstr Surg"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-009-9023-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-009-9023-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-009-9023-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T05:28:06Z","timestamp":1739251686000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-009-9023-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,24]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["9023"],"URL":"https:\/\/doi.org\/10.1007\/s12640-009-9023-3","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,24]]}}}